Colitis, Ulcerative Clinical Trials in Indianapolis, Indiana

3 studies are recruiting for colitis, ulcerative in Indianapolis, Indiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

    The purpose of this study is to evaluate long-term safety of subcutaneous guselkumab in pediatric participants with moderately to severely active ulcerative colitis, or moderately to severely active Crohn's disease, or juvenile psoriatic arthritis (jPsA).

    Stage
    Phase 3
    Ages
    3 and older
    Site
    Riley Hospital for Children, Indianapolis, Indiana
    Locations
    49 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT06663332 on ClinicalTrials.gov

  2. A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

    The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the co…

    Stage
    Phase 3
    Ages
    12 and older
    Site
    IU Health University Hospital, Indianapolis, Indiana
    Locations
    401 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07196748 on ClinicalTrials.gov

  3. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

    The purpose of this study is to evaluate the effectiveness and safety of ozanimod (RPC1063) in achieving and maintaining clinical remission. Ozanimod will be administered orally to pediatric participants with moderate to severe active ulcerative colitis (UC) who have had an inadequate response to c…

    Stage
    Phase 2
    Ages
    2 to 17
    Site
    Local Institution - 0100, Indianapolis, Indiana
    Locations
    90 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT05076175 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.